ECErwin Iván Campos

Erwin Iván Campos

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Erwin Iván Campos has a total of 75 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Algoritmo del consenso dominicano para el abordaje y tratamiento de hipercalemia aguda y crónica

    by Eliana Diná-Batlle, Erwin Campos, Ronald Valdez, Adhanellys Cáceres, Silvano Rodríguez, Jorge Rico-Fontalvo, Vicente Sánchez-Polo, Anthony Gutiérrez-Martínez, Guillermo Álvarez

    Introduction: Hyperkalemia is a potentially fatal electrolyte disorder that is particularly common in patients with chronic kidney disease (CKD), diabetes mellitus, and heart failure, and its management varies widely in clinical practice in the Dominican Republic. The consequences of inadequate management include serious cardiovascular events, hospitalizations, and discontinuation of renoprotective therapies. Objective: To develop a national consensus algorithm for the standardized management and treatment of acute and chronic hyperkalemia in adults, tailored to clinical practice and therapeutic availability in the Dominican Republic. Methodology: A structured methodology based on the GRADE approach was applied, including a critical review of international guidelines and clinical trials (2020–2024), prioritizing evidence applicable to Latin America. Recommendations were classified according to their strength and quality, incorporating the expert judgment of Dominican nephrologists. The algorithm addresses the definition, diagnosis, triage, stepwise treatment, chronic management strategies, and implementation measures at different levels of care. Conclusions: The algorithm proposes a stepwise approach to acute hyperkalemia (≥6.5 mEq/L or abnormal ECG) that includes cardiac stabilization, potassium redistribution, effective elimination, and continuous monitoring. In chronic settings, dietary education, regular monitoring, and the rational use of diuretics, sodium-glucose cotransporter 2 (SGLT2) inhibitors, and resins are recommended. This consensus serves as a practical tool to standardize the management of hyperkalemia and reduce its complications in the country.

  • Open Access

    Correlation Between Glycemic Biomarkers and Continuous Glucose Monitoring Metrics in Chronic Kidney Disease: A Systematic Review and Correlation Meta-Analysis

    by Miguel Angel Cuevas-Budhart, Karen Gómez-Rosas, Rubén David Saavedra-Fernández, Marcela Ávila-Díaz, Erwin Campos, Aldo Ferreira-Hermosillo, Alfonso Ramos-Sánchez, Iván Cavero-Redondo, Ramón Paniagua

    Background/Objectives: Accurate assessment of glycemic control in patients with diabetes and chronic kidney disease (CKD) is challenging because alterations associated with CKD affect the performance of conventional glycemic biomarkers, such as glycated hemoglobin (HbA1c), glycated albumin (GA), and fructosamine, while continuous glucose monitoring (CGM) offers a more comprehensive assessment of glycemic exposure; however, a quantitative synthesis of the correlation between these biomarkers and CGM-derived metrics across CKD stages is lacking. To systematically evaluate the correlation between HbA1c, GA, and fructosamine and CGM-derived glycemic metrics in adults with diabetes and CKD, using CGM as the reference standard. Methods: A systematic review with correlation meta-analysis was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines, including studies published between January 2016 and March 2025, indexed in PubMed, Scopus, and Web of Science. Correlation coefficients were transformed using Fisher’s z transformation and pooled using a random-effects model; heterogeneity was assessed using the I2 statistic. Results: Ten studies met the eligibility criteria; six provided sufficient data for meta-analysis. The pooled correlation was moderate (r = 0.66; 95% confidence interval [CI]: 0.56–0.74) with substantial heterogeneity (I2 = 58.9%). In exploratory biomarker-specific subgroup analyses, GA showed the numerically highest correlation with CGM-derived metrics (r = 0.74; 95% CI: 0.65–0.81), followed by HbA1c (r = 0.65; 95% CI: 0.51–0.75); fructosamine was more variable. Conclusions: No single biomarker demonstrated consistent superiority across CKD stages and treatment modalities. These correlation analyses measure linear association, not clinical interchangeability. Biomarker selection should be individualized according to CKD stage, dialysis status, and CGM availability.

  • Ten-year implementation of a National Peritoneal Dialysis Program in the Dominican Republic: A retrospective study

    by Sergio Óscar Hernández Ordóñez, Erwin Iván Campos Echavarría, Elianny Sarina Polanco Brazoban, Zulma Bolena Lara Mayorga, Miguel Ángel Cuevas Budhart, José Carolino Divino-Filho, Janny Katherine, Alexandra Encarnación Ogando, Yocasta Lara Hernández, Alfonso Ramos-Sánchez

    Background: Chronic kidney disease (CKD) represents a growing public health challenge worldwide, particularly in countries with a medium sociodemographic index such as the Dominican Republic (DR), where both the incidence and prevalence of CKD have shown a sustained increase. In response, the DR government launched a national peritoneal dialysis (PD) program in 2013 to expand access to kidney replacement therapy (KRT). Methods: A retrospective analysis was conducted on the development and implementation of the national continuous ambulatory peritoneal dialysis (CAPD) program over ten years. The model was structured around three pillars: (1) a multidisciplinary team comprising nephrology, nursing, nutrition, psychology, and social work; (2) dedicated infrastructure for PD delivery; and (3) a management system driven by standardized processes and protocols, aligned with ISO certification standards. Patient care involved comprehensive baseline assessments, structured training, monthly follow-up, routine retraining, and home evaluations. Program performance was monitored through predefined clinical indicators. Results: Since the implementation of the program, the PD penetration in DR increased from 2.7% to 22.4%, reaching 1118 patients by the end of 2024. This growth reflects the program's ability to improve access to KRT through a centralized and standardized care model. This model not only facilitated consistency in care delivery across participating centers but also enhanced the growth of PD. Conclusions: The 10-year experience of the national PD program in the DR provides evidence for the feasibility and effectiveness of a standardized, patient-centered, and multidisciplinary PD program. The implementation of this program has significantly increased access to kidney replacement therapies and driven the sustained growth of KRT in the DR and provides a scalable model for the implementation of national PD initiatives in similar contexts.

  • Open Access

    Declaração de Santo Domingo: compromisso com a melhoria da educação, das regulamentações, das políticas públicas e do acesso à diálise peritoneal na América Latina

    by Gustavo L. Moretta-Pedernera, Alfonso Ramos-Sánchez, Laura Cortés-Sanabria, Rosana Chaúd-Covarrubias, Guillermo Álvarez-Estévez, Mauricio Uribe, Vicente Sánchez-Polo, José Carolino Divino-Filho, Natalia M. Wasmuth-Troche, Ledisbeth Batista-Buitrago, et al.

    Resumo A Declaração de Santo Domingo destaca os desafios e as oportunidades para aprimorar a educação, as regulamentações, as políticas públicas e o acesso à diálise peritoneal (DP) na América Latina. Enfatiza a necessidade de enfrentar desigualdades estruturais na formação e na assistência, estabelecendo padrões mínimos de competências e fortalecendo a infraestrutura de saúde. Inspirada em iniciativas como o Standardized Outcomes in Nephrology–Peritoneal Dialysis (SONG-PD) e o European Specialty Examination in Nephrology (ESENeph), a declaração ressalta a importância da harmonização na formação dos nefrologistas, promovendo uma capacitação uniforme e alinhada aos padrões internacionais. Além disso, aborda estratégias para priorizar a qualidade de vida dos pacientes, garantir acessibilidade e sustentabilidade econômica, e incentivar a implementação de unidades satélites e tecnologias inovadoras. Por fim, faz um chamado à colaboração intersetorial para assegurar um cuidado inclusivo e equitativo na região.

  • Open Access

    Elementos de custo a serem considerados em estimativas para estudos de microcusteio em terapia de diálise peritoneal (DP) na América Latina

    by Celso Souza de Moraes- Júnior, Natalia Orihuela, Natália Maria da Silva Fernandes, Laura Cortes Sanabria, Luciane Senra de Souza Braga, Pablo Amair, Uriel Winik, Angelica Viviana Manchinelli, Marta Susana Adragna, Eliseo Antonio Guzmán, et al.

    Resumo Introdução: As principais ferramentas para a tomada de decisões clínicas baseadas no uso eficiente de recursos são estudos de avaliação econômica que permitem avaliar tanto os custos quanto os benefícios de diferentes terapêuticas, com diretrizes adequadas para a elaboração de relatórios. Este estudo teve como objetivo desenvolver um checklist de elementos de custo de consumo a serem considerados em estimativas para estudos de microcusteio em diálise peritoneal (DP). Métodos: Foram trabalhadas quatro etapas, seguidas de análise e interpretação dos dados. Três etapas foram realizadas para o desenvolvimento do questionário de elementos de custo direto: 1ª – elaboração da primeira versão do checklist; 2ª – avaliação e expansão com a aplicação do método Delphi; 3ª – realização de dois painéis de especialistas; e 4ª – aplicação do questionário a profissionais de 18 países latino-americanos. Critérios de inclusão: profissionais com pelo menos um ano de experiência clínica e/ou administrativa em DP. Foi realizado um ajuste por distribuição de probabilidade discreta. Foram considerados lotes de distribuição por categoria de elementos de custo por país. Aplicou-se o método de estimação por máxima verossimilhança, e a classificação estatística dos ajustes foi estimada utilizando o Critério de Informação de Akaike. Resultados: Foram validados 596 questionários, com sete dimensões e 41 elementos. A partir dos resultados de cada lote, foi possível segmentar os elementos em três opções de escolha, com probabilidade de avaliar um elemento como muito importante, classificando assim os elementos de custo. Conclusão: O checklist favorece um dimensionamento econômico mais equitativo em estudos comparativos, possibilitando a comparação de valores econômicos em DP entre países, considerando os elementos de custo adequados.

  • Open Access

    Declaration of Santo Domingo: commitment to improve education, regulations, public policies, and access to peritoneal dialysis in Latin America

    by Gustavo L. Moretta-Pedernera, Alfonso Ramos-Sánchez, Laura Cortés-Sanabria, Rosana Chaúd-Covarrubias, Guillermo Álvarez-Estévez, Mauricio Uribe, Vicente Sánchez-Polo, José Carolino Divino-Filho, Natalia M. Wasmuth-Troche, Ledisbeth Batista-Buitrago, et al.

    The Santo Domingo Declaration highlights the challenges and opportunities to improve education, regulations, public policies, and access to peritoneal dialysis (PD) in Latin America. It emphasizes the need to address structural inequalities in training and care, establishing minimum competency standards and strengthening health infrastructure. Inspired by initiatives such as the Standardised Outcomes in Nephrology–Peritoneal Dialysis (SONG-PD) and the European Specialty Examination in Nephrology (ESENeph), the declaration underlines the importance of harmonizing nephrologist training to promote standardised and internationally aligned competencies. Additionally, it outlines strategies to prioritize patients’ quality of life, ensure accessibility and economic sustainability, and foster the implementation of satellite units and innovative technologies. Finally, it calls for intersectoral collaboration to ensure inclusive and equitable healthcare in the region.

  • Open Access

    Cost elements to be considered in estimates for microcosting studies in peritoneal dialysis (PD) therapy in Latin America

    by Celso Souza de Moraes- Júnior, Natalia Orihuela, Natália Maria da Silva Fernandes, Laura Cortes Sanabria, Luciane Senra de Souza Braga, Pablo Amair, Uriel Winik, Angelica Viviana Manchinelli, Marta Susana Adragna, Eliseo Antonio Guzmán, et al.

    Introduction: The main tools for making clinical decisions based on efficient use of resources are economic evaluation studies that allow the assessment of both the costs and benefits of different therapeutics, with appropriate guidelines for preparing reports. This study aimed to develop a checklist of consumable cost elements to be considered in estimates for micro-costing studies in peritoneal dialysis (PD). Methods: Four stages were conducted, followed by data analysis and interpretation. Three stages were carried out to develop the direct cost elements questionnaire: 1st — designing the first version of the checklist; 2nd — evaluating and expanding it using the Delphi method; 3rd — conducting two expert panels; and 4th — applying the questionnaire to professionals from 18 Latin American countries. Inclusion criteria: professionals with at least one year of clinical and/or administrative experience in PD. A discrete probability distribution adjustment was performed. Distribution lots were considered according to the category of cost elements for each country. The maximum likelihood estimation method was applied, and the statistical classification of the adjustments was assessed using the Akaike Information Criterion. Results: A total of 596 questionnaires, comprising seven dimensions and 41 elements, were validated. From the results of each batch, it was possible to segment the elements into three choice options, with the probability of evaluating an element as very important, thus allowing for the classification of the cost elements. Conclusion: The checklist favors more equitable economic dimensioning in comparative studies, making it possible to compare economic values in PD across countries, while considering the appropriate cost elements.

  • Open Access

    National dialysis registry of the Dominican Republic: first nationwide epidemiological analysis of renal replacement therapy

    by Adhanellys Cáceres-Murillo, Erwin Iván Campos, Hector Martínez, Ana Carolina De La Cruz, Gertrudis De La Cruz, Wendy Rodríguez, Rafael Robles, Rafael Martínez, Yamile Anaya-Jimenez, Miguel Angel Cuevas-Budhart, et al.

    Kidney failure is a growing global health concern, affecting 9-10% of the population and contributing to rising mortality. In the Dominican Republic, a national dialysis registry was created in 2020 to monitor patients receiving kidney replacement therapy (KRT). Yet no comprehensive national epidemiological report has been published to date. We conducted a nationwide, cross-sectional study using data from the 2022 Dominican National Dialysis Registry, encompassing all patients, both private and public, on hemodialysis (HD) or peritoneal dialysis (PD) in National Health Service, authorized units. Data were collected via a standardized digital form (August-September 2023) and analyzed using IBM SPSS Statistics v22. A total of 4,690 patients were recorded, median age 56 years (SD ± 15.6), 69% male. HD predominated (78.4%). Hypertension (93.9%) and diabetes mellitus (44.4%) were the most frequent comorbidities, with diabetes more common in PD than HD (52.5% vs. 42.2%). In HD, arteriovenous fistula was the primary access (61.2%); in PD, continuous ambulatory peritoneal dialysis (CAPD) was predominant (80.4%). National prevalence reached 421.8 patients per million population (91.1 ppm PD, 330.7 ppm HD), a 6% increase from 2022. This first nationwide analysis provides a comprehensive characterization of the epidemiological profile of KRT in the Dominican Republic, revealing the dominance of HD, the high burden of cardiovascular and metabolic comorbidities, and rising prevalence rates. These findings underscore the urgent need to strengthen kidney failure prevention, improve early detection, and enhance the integration of PD within a balanced renal care strategy aligned with regional best practices.


  • Open Access

    A COVID‐19 pandemic‐specific, structured care process for peritoneal dialysis patients facilitated by telemedicine: Therapy continuity, prevention, and complications management

    by Elianny Polanco, Mercedes Aquey, Jhanna Collado, Erwin Campos, Janny Guzman, Miguel Angel Cuevas‐Budhart, José Carolino Divino‐Filho, Alfonso Ramos‐Sanchez

    Coronavirus disease 2019 (COVID‐19) has been declared a pandemic. Peritoneal dialysis (PD), being a home therapy, allows for physical distancing measures and movement restrictions. In order to prevent COVID‐19 contagioun among the Dominican Republic National Health System PD program patients, a follow‐up virtual protocol for this group was developed. The aim of this study is to outline the protocol established by the PD program's healthcare team using telemedicine in order to avoid COVID‐19 transmission and to report initial results and outcomes of this initiative. This is an observational prospective longitudinal study with 946 patients being treated in seven centers distributed throughout the country between April 1 and June 30. The protocol was implemented focusing on the patient follow‐up; risk mitigation data were registered and collected from electronic records. During the follow‐up period, 95 catheters were implanted, 64 patients initiated PD, and the remaining were in training. A total of 9532 consultations were given by the different team specialists, with 8720 (91%) virtual and 812 (9%) face‐to‐face consultations. The transfer rate to hemodialysis was 0.29%, whereas the peritonitis rate was 0.11 episode per patient/year. Eighteen adults tested positive for COVID‐19. The implementation of the protocol and telemedicine utilization have ensured follow‐up and monitoring, preserved therapy, controlled complications, and PD lives protected.